KEYTRUDA: payments to doctors
Payments that named KEYTRUDA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $43.8M
- Providers
- 34,073
- Transactions
- 241,040
- Average per transaction
- $182
The per-transaction average — $182 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 34,073 providers the average total is $1,287, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Merck | $43,807,303 | 99.9% |
| Comsort, Inc | $33,350 | 0.1% |